MedTrace Logo

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

NCT05965908 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-03-06

No results posted yet for this study

Summary

The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.

Conditions

  • Polycystic Ovary

Interventions

DRUG

liraglutide

glucagon-like peptide 1 receptor agonist

DRUG

Metformin

biguanide antihyperglycemic

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Beni-Suef University · Clinical Pharmacy Faculty of Pharmacy Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2025-03-30
Completion
2025-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05965908 on ClinicalTrials.gov